{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:38:52Z","timestamp":1793194732848,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T00:00:00Z","timestamp":1685145600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020-117939RB-I00"],"award-info":[{"award-number":["PID2020-117939RB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-107363RB-I00"],"award-info":[{"award-number":["PID2019-107363RB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1A2C2007243"],"award-info":[{"award-number":["2021R1A2C2007243"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/01616"],"award-info":[{"award-number":["PI19\/01616"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002911","name":"Universidad Complutense de Madrid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002911","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022766","name":"Fundaci\u00f3n Contra la Hipertensi\u00f3n Pulmonar","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022766","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.biopha.2023.114952","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T17:38:33Z","timestamp":1686159513000},"page":"114952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The novel KV7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit"],"prefix":"10.1016","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3879-3056","authenticated-orcid":false,"given":"Marta","family":"Villegas-Esguevillas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhan","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4040-1920","authenticated-orcid":false,"given":"Alba","family":"Vera-Zambrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Won","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0338-8456","authenticated-orcid":false,"given":"Bianca","family":"Barreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0028-6769","authenticated-orcid":false,"given":"G\u00f6cken","family":"Telli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Navarro-Dorado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1692-4633","authenticated-orcid":false,"given":"Daniel","family":"Morales-Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"de Olaiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"P\u00e9rez-Vizca\u00edno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Climent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Cogolludo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.114952_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pharmthera.2016.05.002","article-title":"Novel treatment strategies for smooth muscle disorders: Targeting Kv7 potassium channels","volume":"165","author":"Haick","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2023.114952_bib2","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1124\/mol.108.049825","article-title":"Cardiovascular KCNQ (Kv7) potassium channels: Physiological regulators and new targets for therapeutic intervention","volume":"74","author":"Mackie","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2023.114952_bib3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1146\/annurev-pharmtox-010617-052912","article-title":"KCNQ-encoded potassium channels as therapeutic targets","volume":"58","author":"Barrese","year":"2018","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2023.114952_bib4","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1111\/bph.14662","article-title":"Activation of Kv7 channels as a novel mechanism for NO\/cGMP-induced pulmonary vasodilation","volume":"176","author":"Mond\u00e9jar-Parre\u00f1o","year":"2019","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2023.114952_bib5","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1161\/HYPERTENSIONAHA.120.15221","article-title":"Uncovered contribution of Kv7 channels to pulmonary vascular tone in pulmonary arterial hypertension","author":"Mond\u00e9jar-Parre\u00f1o","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2023.114952_bib6","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1124\/jpet.108.147785","article-title":"KCNQ modulators reveal a key role for KCNQ potassium channels in regulating the tone of rat pulmonary artery smooth muscle","volume":"329","author":"Joshi","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2023.114952_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/biom12030429","article-title":"Kv7 channels in cyclic\u2010nucleotide dependent relaxation of rat intra\u2010pulmonary artery","volume":"12","author":"Al\u2010chawishly","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2023.114952_bib8","first-page":"363","article-title":"World Health Organization Group I pulmonary hypertension: epidemiology and pathophysiology","volume":"34","author":"Prins","year":"2016","journal-title":"Cardiol. Clin."},{"key":"10.1016\/j.biopha.2023.114952_bib9","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2023.114952_bib10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrcardio.2011.87","article-title":"Mechanisms of disease: Pulmonary arterial hypertension","volume":"8","author":"Schermuly","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2023.114952_bib11","series-title":"Br J Pharmacol","article-title":"Potassium channels in the regulation of pulmonary artery smooth muscle cell proliferation and apoptosis: Pharmacotherapeutic implications","author":"Burg","year":"2008"},{"key":"10.1016\/j.biopha.2023.114952_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000097754","article-title":"Mechanisms controlling vascular tone in pulmonary arterial hypertension: Implications for vasodilator therapy","volume":"79","author":"Cogolludo","year":"2007","journal-title":"Pharmacology"},{"key":"10.1016\/j.biopha.2023.114952_bib13","doi-asserted-by":"crossref","first-page":"L202","DOI":"10.1152\/ajplung.2001.281.1.L202","article-title":"Partial HIF-1 deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia","volume":"281","author":"Shimoda","year":"2001","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biopha.2023.114952_bib14","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1152\/ajplung.00379.2004","article-title":"Chronic hypoxia inhibits Kv channel gene expression in rat distal pulmonary artery","volume":"288","author":"Wang","year":"2005","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biopha.2023.114952_bib15","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/01.CIR.98.14.1400","article-title":"Dysfunctional voltage-gated K channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension","volume":"98","author":"Xiao-Jian Yuan","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2023.114952_bib16","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1476-5381.2009.00283.x","article-title":"Treatment with the Kv7 potassium channel activator flupirtine is beneficial in two independent mouse models of pulmonary hypertension","volume":"157","author":"Morecroft","year":"2009","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2023.114952_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1152\/ajplung.00362.2013","article-title":"Role of Kv7 channels in responses of the pulmonary circulation to hypoxia","volume":"308","author":"Sedivy","year":"2015","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biopha.2023.114952_bib18","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1152\/ajplung.00130.2018","article-title":"Hypoxia inhibits adenylyl cyclase catalytic activity in a porcine model of persistent pulmonary hypertension of the newborn","volume":"315","author":"Sikarwar","year":"2018","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biopha.2023.114952_bib19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1124\/jpet.109.160119","article-title":"Impaired vasoconstriction and nitric oxide-mediated relaxation in pulmonary arteries of hypoxia- and monocrotaline-induced pulmonary hypertensive rats","volume":"332","author":"Mam","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2023.114952_bib20","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1124\/jpet.117.244798","article-title":"Impaired pulmonary arterial vasoconstriction and nitric oxide\u2013mediated relaxation underlie severe pulmonary hypertension in the sugen-hypoxia rat model","volume":"364","author":"Christou","year":"2018","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biopha.2023.114952_bib21","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1183\/13993003.01259-2015","article-title":"Vascular effects of sildenafil in patients with pulmonary fibrosis and pulmonary hypertension: an ex vivo\/in vitro study","volume":"47","author":"Milara","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.biopha.2023.114952_bib22","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3389\/fphys.2020.00634","article-title":"Kv7 channels in lung diseases","volume":"11","author":"Mondejar-Parre\u00f1o","year":"2020","journal-title":"Front Physiol."},{"key":"10.1016\/j.biopha.2023.114952_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.00583","article-title":"KCNQs: ligand- and voltage-gated potassium channels","volume":"11","author":"Abbott","year":"2020","journal-title":"Front Physiol."},{"key":"10.1016\/j.biopha.2023.114952_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/micc.12419","article-title":"Kv7 potassium channels as signal transduction intermediates in the control of microvascular tone","volume":"25","author":"Byron","year":"2018","journal-title":"Microcirculation"},{"key":"10.1016\/j.biopha.2023.114952_bib25","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1113\/JP271286","article-title":"Fundamental role for the KCNE4 ancillary subunit in Kv7.4 regulation of arterial tone","volume":"593","author":"Jepps","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/j.biopha.2023.114952_bib26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000449060","article-title":"KCNE4 deletion sex-dependently alters vascular reactivity","volume":"53","author":"Abbott","year":"2016","journal-title":"J. Vasc. Res"},{"key":"10.1016\/j.biopha.2023.114952_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/antiox10020155","article-title":"Oxygen-sensitivity and pulmonary selectivity of vasodilators as potential drugs for pulmonary hypertension","volume":"10","author":"Morales-Cano","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2023.114952_bib28","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1016\/j.bmcl.2018.09.036","article-title":"Novel KV7 ion channel openers for the treatment of epilepsy and implications for detrusor tissue contraction","volume":"28","author":"Seefeld","year":"2018","journal-title":"Bioorg. Med Chem. Lett."},{"key":"10.1016\/j.biopha.2023.114952_bib29","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4196\/kjpp.2020.24.6.503","article-title":"The agonistic action of URO-K10 on Kv7.4 and 7.5 channels is attenuated by co-expression of KCNE4 ancillary subunit","volume":"24","author":"Lee","year":"2020","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2023.114952_bib30","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/thoraxjnl-2015-208067","article-title":"Role of acid sphingomyelinase and IL-6 as mediators of endotoxin-induced pulmonary vascular dysfunction","volume":"72","author":"Pandolfi","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.biopha.2023.114952_bib31","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/cvr\/cvn349","article-title":"Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction","volume":"82","author":"Cogolludo","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.biopha.2023.114952_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.RES.41.1.19","article-title":"Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats","volume":"41","author":"Mulvany","year":"1997","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2023.114952_bib33","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1152\/ajplung.1998.275.6.L1069","article-title":"Role of wall tension in hypoxic responses of isolated rat pulmonary arteries","volume":"19","author":"Ozaki","year":"1998","journal-title":"Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.biopha.2023.114952_bib34","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/cvr\/cvn349","article-title":"Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction","volume":"82","author":"Cogolludo","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2023.114952_bib35","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/sj.bjp.0701257","article-title":"Involvement of protein kinase C in reduced relaxant responses to the NO\/cyclic GMP pathway in piglet pulmonary arteries contracted by the thromboxane A 2-mimetic U46619 1","volume":"121","author":"P\u00e9rez-Vizcaino","year":"1997","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2023.114952_bib36","first-page":"249","article-title":"Lack of endotoxin-induced hyporesponsiveness to U46619 in isolated neonatal porcine pulmonary but not mesenteric arteries","volume":"33","author":"P\u00e9rez-Vizca\u00edno","year":"1996","journal-title":"J. Vasc. Res"},{"key":"10.1016\/j.biopha.2023.114952_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114492","article-title":"The flavonoid quercetin reverses pulmonary hypertension in rats","volume":"9","author":"Morales-Cano","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.114952_bib38","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1161\/01.RES.0000216858.04599.e1","article-title":"Serotonin inhibits voltage-gated K+ currents in pulmonary artery smooth muscle cells: Role of 5-HT2A receptors, caveolin-1, and KV1.5 channel internalization","volume":"98","author":"Cogolludo","year":"2006","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2023.114952_bib39","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1152\/ajplung.00045.2018","article-title":"HIV transgene expression impairs K channel function in the pulmonary vasculature","volume":"315","author":"Mondejar-Parre\u00f1o","year":"2018","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biopha.2023.114952_bib40","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/cvr\/cvv020","article-title":"Kv7 channels critically determine coronary artery reactivity: Left-right differences and down-regulation by hyperglycaemia","volume":"106","author":"Morales-Cano","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.biopha.2023.114952_bib41","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2174\/156802607780487740","article-title":"Morpholino, siRNA, and S-DNA compared: impact of structure and mechanism of action on off-target effects and sequence specificity","volume":"7","author":"Summerton","year":"2007","journal-title":"Curr. Top. Med Chem."},{"key":"10.1016\/j.biopha.2023.114952_bib42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0167-4781(99)00150-5","article-title":"Morpholino antisense oligomers: the case for an RNase H-independent structural type","volume":"1489","author":"Summerton","year":"1999","journal-title":"Biochim. Et. Biophys. Acta"},{"key":"10.1016\/j.biopha.2023.114952_bib43","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1113\/JP276054","article-title":"miR-1 is increased in pulmonary hypertension and downregulates Kv1.5 channels in rat pulmonary arteries.","volume":"597","author":"Mondejar-Parre\u00f1o","year":"2019","journal-title":"J. Physiol."},{"key":"10.1016\/j.biopha.2023.114952_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106684","article-title":"Sigma-1 receptor modulation fine-tunes KV1.5 channels and impacts pulmonary vascular function.","volume":"189","author":"Vera-Zambrano","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2023.114952_bib45","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1476-5381.2009.00353.x","article-title":"Organ culture mimics the effects of hypoxia on membrane potential, K(+) channels and vessel tone in pulmonary artery","volume":"158","author":"Manoury","year":"2009","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2023.114952_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114222","article-title":"Metabolic syndrome inhibits store-operated Ca2+ entry and calcium-induced calcium-release mechanism in coronary artery smooth muscle","volume":"182","author":"Climent","year":"2020","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2023.114952_bib47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/bph.14112","article-title":"Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology.","volume":"175","author":"Alexander","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2023.114952_bib48","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/HYPERTENSIONAHA.114.04373","article-title":"Contribution of Kv7 channels to natriuretic peptide mediated vasodilation in normal and hypertensive rats","volume":"65","author":"Stott","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2023.114952_bib49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/cvr\/cvv020","article-title":"Kv7 channels critically determine coronary artery reactivity: left-right differences and down-regulation by hyperglycaemia","volume":"106","author":"Morales-Cano","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.biopha.2023.114952_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176019","article-title":"Remodeling of Kv7.1 and Kv7.5 Expression in Vascular Tumors.","volume":"21","author":"Serrano-Novillo","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114952_bib51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000095158","article-title":"Functional coassembly of KCNQ4 with KCNE-\u03b2-subunits in xenopus oocytes","volume":"18","author":"Strutz-Seebohm","year":"2006","journal-title":"Cell Physiol. Biochem"},{"key":"10.1016\/j.biopha.2023.114952_bib52","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s13105-019-00696-2","article-title":"miR-1 induces endothelial dysfunction in rat pulmonary arteries","volume":"75","author":"Mondejar-Parre\u00f1o","year":"2019","journal-title":"J. Physiol. Biochem"},{"key":"10.1016\/j.biopha.2023.114952_bib53","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/cvr\/cvy016","article-title":"Loss of KCNK3 is a hallmark of RV hypertrophy\/dysfunction associated with pulmonary hypertension","volume":"114","author":"Lambert","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.biopha.2023.114952_bib54","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1172\/JCI119774","article-title":"Hypoxia inhibits gene expression of voltage-gated K1 channel a subunits inpulmonary artery smooth muscle cells","volume":"100","author":"Wang","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2023.114952_bib55","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1161\/01.RES.0000099883.68414.61","article-title":"Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells","volume":"93","author":"Gurney","year":"2003","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2023.114952_bib56","first-page":"L621","article-title":"Molecular basis and function of voltage-gated K channels in pulmonary arterial smooth muscle cells","volume":"274","author":"Yuan","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.biopha.2023.114952_bib57","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00754-2017","article-title":"TASK-1 (KCNK3) channels in the lung: From cell biology to clinical implications","volume":"50","author":"Olschewski","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.biopha.2023.114952_bib58","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/CIRCULATIONAHA.115.020951","article-title":"Potassium channel subfamily K member 3 (KCNK3) contributes to the development of pulmonary arterial hypertension","volume":"133","author":"Antigny","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2023.114952_bib59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1476-5381.2012.02133.x","article-title":"One man\u2019s side effect is another man\u2019s therapeutic opportunity: Targeting Kv7 channels in smooth muscle disorders","volume":"168","author":"Jepps","year":"2013","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2023.114952_bib60","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.drudis.2013.12.003","article-title":"KV7 potassium channels: A new therapeutic target in smooth muscle disorders","volume":"19","author":"Stott","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2023.114952_bib61","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1039\/D0MD00328J","article-title":"Chemical modulation of Kv7 potassium channels","volume":"12","author":"Borgini","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.biopha.2023.114952_bib62","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1528-1167.2012.03441.x","article-title":"The urinary safety profile and secondary renal effects of retigabine (ezogabine): A first-in-class antiepileptic drug that targets KCNQ (K v 7) potassium channels","volume":"53","author":"Brickel","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.biopha.2023.114952_bib63","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00428-011-1087-9","article-title":"Pathology of flupirtine-induced liver injury: a histological and clinical study of six cases","volume":"458","author":"Puls","year":"2011","journal-title":"Virchows Arch."},{"key":"10.1016\/j.biopha.2023.114952_bib64","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1365-2125.2011.04138.x","article-title":"Unexpected frequent hepatotoxicity of a prescription drug, flupirtine, marketed for about 30 years","volume":"73","author":"Michel","year":"2012","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.biopha.2023.114952_bib65","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/bph.14910","article-title":"Vasodilation of rat skeletal muscle arteries by the novel BK channel opener GoSlo is mediated by the simultaneous activation of BK and Kv 7 channels","volume":"177","author":"Zavaritskaya","year":"2020","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2023.114952_bib66","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/ATVBAHA.111.242727","article-title":"Kv1.3 channels can modulate cell proliferation during phenotypic switch by an ion-flux independent mechanism","volume":"32","author":"Cidad","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2023.114952_bib67","doi-asserted-by":"crossref","first-page":"8116","DOI":"10.1038\/ncomms9116","article-title":"Atomic basis for therapeutic activation of neuronal potassium channels","volume":"6","author":"Kim","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.114952_bib68","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1124\/mol.104.010793","article-title":"The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate","volume":"67","author":"Wuttke","year":"2005","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2023.114952_bib69","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1124\/mol.108.052282","article-title":"Refinement of the binding site and mode of action of theanticonvulsant Retigabine on KCNQ K+channels","volume":"75","author":"Lange","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2023.114952_bib70","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1523\/JNEUROSCI.0128-05.2005","article-title":"Molecular determinants of KCNQ (K v 7) K channel sensitivity to the anticonvulsant retigabine","volume":"25","author":"Schenzer","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2023.114952_bib71","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1152\/ajplung.00475.2019","article-title":"Vitamin D deficiency downregulates TASK-1 channels and induces pulmonary vascular dysfunction","volume":"319","author":"Callejo","year":"2020","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biopha.2023.114952_bib72","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.amjcard.2017.06.012","article-title":"The nitric oxide pathway in pulmonary vascular disease","volume":"120","author":"Klinger","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.biopha.2023.114952_bib73","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01889-2018","article-title":"Risk stratification and medical therapy of pulmonary arterial hypertension","volume":"53","author":"Gali\u00e8","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.biopha.2023.114952_bib74","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/bph.15722","article-title":"Sexual dimorphism in prostacyclin-mimetic responses within rat mesenteric arteries: A novel role for KV 7.1 in shaping IP receptor-mediated relaxation","volume":"179","author":"Baldwin","year":"2022","journal-title":"Br. J. Pharm."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223007424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223007424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:13:07Z","timestamp":1793193187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223007424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":74,"alternative-id":["S0753332223007424"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114952","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The novel KV7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114952"}}